Cargando…
Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines
Cancer is a leading cause of morbidity and mortality worldwide. Apoptosis is a process of programmed cell death and it plays a vital role in human development and tissue homeostasis. Mounting evidence indicates that apoptosis is closely related to the survival of cancer and it has emerged as a key t...
Autores principales: | , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639427/ https://www.ncbi.nlm.nih.gov/pubmed/31354479 http://dx.doi.org/10.3389/fphar.2019.00758 |
_version_ | 1783436465821188096 |
---|---|
author | An, Weixiao Lai, Honglin Zhang, Yangyang Liu, Minghua Lin, Xiukun Cao, Shousong |
author_facet | An, Weixiao Lai, Honglin Zhang, Yangyang Liu, Minghua Lin, Xiukun Cao, Shousong |
author_sort | An, Weixiao |
collection | PubMed |
description | Cancer is a leading cause of morbidity and mortality worldwide. Apoptosis is a process of programmed cell death and it plays a vital role in human development and tissue homeostasis. Mounting evidence indicates that apoptosis is closely related to the survival of cancer and it has emerged as a key target for the discovery and development of novel anticancer drugs. Various studies indicate that targeting the apoptotic signaling pathway by anticancer drugs is an important mechanism in cancer therapy. Therefore, numerous novel anticancer agents have been discovered and developed from traditional Chinese medicines (TCMs) by targeting the cellular apoptotic pathway of cancer cells and shown clinically beneficial effects in cancer therapy. This review aims to provide a comprehensive discussion for the role, pharmacology, related biology, and possible mechanism(s) of a number of important anticancer TCMs and their derivatives mainly targeting the cellular apoptotic pathway. It may have important clinical implications in cancer therapy. |
format | Online Article Text |
id | pubmed-6639427 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2019 |
publisher | Frontiers Media S.A. |
record_format | MEDLINE/PubMed |
spelling | pubmed-66394272019-07-26 Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines An, Weixiao Lai, Honglin Zhang, Yangyang Liu, Minghua Lin, Xiukun Cao, Shousong Front Pharmacol Pharmacology Cancer is a leading cause of morbidity and mortality worldwide. Apoptosis is a process of programmed cell death and it plays a vital role in human development and tissue homeostasis. Mounting evidence indicates that apoptosis is closely related to the survival of cancer and it has emerged as a key target for the discovery and development of novel anticancer drugs. Various studies indicate that targeting the apoptotic signaling pathway by anticancer drugs is an important mechanism in cancer therapy. Therefore, numerous novel anticancer agents have been discovered and developed from traditional Chinese medicines (TCMs) by targeting the cellular apoptotic pathway of cancer cells and shown clinically beneficial effects in cancer therapy. This review aims to provide a comprehensive discussion for the role, pharmacology, related biology, and possible mechanism(s) of a number of important anticancer TCMs and their derivatives mainly targeting the cellular apoptotic pathway. It may have important clinical implications in cancer therapy. Frontiers Media S.A. 2019-07-12 /pmc/articles/PMC6639427/ /pubmed/31354479 http://dx.doi.org/10.3389/fphar.2019.00758 Text en Copyright © 2019 An, Lai, Zhang, Liu, Lin and Cao http://creativecommons.org/licenses/by/4.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. |
spellingShingle | Pharmacology An, Weixiao Lai, Honglin Zhang, Yangyang Liu, Minghua Lin, Xiukun Cao, Shousong Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines |
title | Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines |
title_full | Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines |
title_fullStr | Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines |
title_full_unstemmed | Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines |
title_short | Apoptotic Pathway as the Therapeutic Target for Anticancer Traditional Chinese Medicines |
title_sort | apoptotic pathway as the therapeutic target for anticancer traditional chinese medicines |
topic | Pharmacology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6639427/ https://www.ncbi.nlm.nih.gov/pubmed/31354479 http://dx.doi.org/10.3389/fphar.2019.00758 |
work_keys_str_mv | AT anweixiao apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines AT laihonglin apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines AT zhangyangyang apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines AT liuminghua apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines AT linxiukun apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines AT caoshousong apoptoticpathwayasthetherapeutictargetforanticancertraditionalchinesemedicines |